Submission for OMB Review; Comment Request; Correction, 7525 [E8-2373]

Download as PDF Federal Register / Vol. 73, No. 27 / Friday, February 8, 2008 / Notices incorporated places also constitute MCDs. Nonvisible feature—A map feature that is not visible on the ground, such as a city or county boundary through space, a property line running through space, a short line-of-sight extension of a road to another visible feature, or a point-to-point line of sight. Visible feature—A map feature that can be seen on the ground, such as a road, railroad track, major above-ground transmission line or pipeline, river or stream, shoreline, fence, sharply defined mountain ridge, or cliff. A nonstandard visible feature is a feature that may not be clearly defined on the ground (such as a ridge), may be seasonal (such as an intermittent stream), or may be relatively impermanent (such as a fence). The Census Bureau generally requests verification that nonstandard features pose no problem in their location during fieldwork by Census Bureau staff. Executive Order 12866 This notice has been determined to be not significant under Executive Order 12866. Paperwork Reduction Act This program notice does not represent a collection of information subject to the requirements of the Paperwork Reduction Act, 44 U.S.C., Chapter 35. Dated: February 5, 2008. Steve H. Murdock, Director, Bureau of the Census. [FR Doc. E8–2348 Filed 2–7–08; 8:45 am] BILLING CODE 3510–07–P DEPARTMENT OF COMMERCE Bureau of Economic Analysis Submission for OMB Review; Comment Request; Correction Bureau of Economic Analysis (BEA), Department of Commerce. This notice corrects the notice published on February 1, 2008, Volume 73, Number 22, page 6114. The following items are corrected and replaced— Title: Biomedical Research and Development Price Index (BRDPI) Survey. OMB Control Number: 0608–0069. All other information stated in the February 1, 2008 notice remains effective. pwalker on PROD1PC71 with NOTICES AGENCY: VerDate Aug<31>2005 17:11 Feb 07, 2008 Jkt 214001 Dated: February 5, 2008. Gwellnar Banks, Management Analyst, Office of the Chief Information Officer. [FR Doc. E8–2373 Filed 2–7–08; 8:45 am] BILLING CODE 3510–06–P DEPARTMENT OF COMMERCE Bureau of Industry and Security Action Affecting Export Privileges: AR–AM Medical Services LLC; In the Matter of AR–AM Medical Services LLC; Case No. 06–08 Order The Office of Antiboycott Compliance, Bureau of Industry and Security, U.S. Department of Commerce (‘‘BIS’’), having determined to initiate an administrative proceeding pursuant to Section 11(c) of the Export Administration Act of 1979, as amended (50 U.S.C. 2401–2420 (2000)) (the ‘‘Act’’) 1 and the Export Administration Regulations (currently codified at 15 CFR Parts 730–774 (2007) (the ‘‘Regulations’’), against AR–AM Medical Services LLC (‘‘AR–AM’’), a domestic concern, based on allegations set forth in the Proposed Charging Letter, dated April 17, 2006, that alleged that AR–AM committed three violations of the Regulations; * * * * * Specifically, the charges are: 1. Three Violations of 15 CFR 760.2(d)—Furnishing Information about Business Relationships With Boycotted Countries or Blacklisted Persons: During the years 2001 and 2002, AR–AM engaged in transaction(s) involving the sale and/or transfer of goods or services (including information) from the United States to Syria. In connection with these activities, on three occasions, AR–AM, with intent to comply with, further or support an unsanctioned foreign boycott, furnished information concerning its or another person’s business relationships with or in a 1 From August 21, 1994 through November 12, 2000, the Act was in lapse. During that period, the President, through Executive Order 12924, which had been extended by successive Presidential Notices, the last of which was August 3, 2000 (3 CFR 2000 Comp. 397 (2001)), continued the Regulations in effect under the International Emergency Economic Powers Act (50 U.S.C. 1701– 1706 (2000)) (‘‘IEEPA’’). On November 13, 2000, the Act was reauthorized by Pub. L. 106–508 (114 Stat. 2360 (2000)) and remained in effect through August 20, 2001. Since August 21, 2001, the Act has been in lapse. Executive Order 13222 of August 17, 2001 (3 CFR 2001 Comp 783 (2002)), which has been extended by successive Presidential Notices, the most recent of which was August 15, 2007 (72 FR 46137 (August 16, 2007)), continues the Regulations in effect under IEEPA. PO 00000 Frm 00020 Fmt 4703 Sfmt 4703 7525 boycotted country, an activity prohibited by Section 760.2(d) of the Regulations, and not excepted. BIS and AR–AM having entered into a Settlement Agreement pursuant to Section 766.18(a) of the Regulations whereby the parties have agreed to settle this matter in accordance with the terms and conditions set forth therein and the terms of the Settlement Agreement having been approved by me; It is therefore ordered that: First, a civil penalty of $7,200 is assessed against AR–AM. Payment shall be suspended for a period of two years from the date of entry of this Order and thereafter shall be waived, provided that, during the period of suspension, AR–AM has committed no violation of the Act and Regulations or any order issued thereunder. Second, for a period of two years from the date of entry of this Order, AR–AM Medical Services LLC (Great Neck, New York) (‘‘Denied Person’’) may not participate, directly or indirectly, in any way in any transaction involving any commodity, software or technology (collectively, ‘‘item’’) exported or to be exported from the United States to Bahrain, Iraq, Kuwait, Lebanon, Libya, Oman, Qatar, Saudi Arabia, Syria, the United Arab Emirates or the Republic of Yemen (collectively, the ‘‘Territory’’) that is subject to the Regulations, or in any other activity relating to the Territory that is subject to the Regulations, including, but not limited to: A. Applying for, obtaining, or using any license, License Exception, or export control document, relating to the Territory; B. Carrying on negotiations concerning, or ordering, buying, receiving, using, selling, delivering, storing, disposing of, forwarding, transporting, financing, or otherwise servicing in any way, any transaction involving any item exported or to be exported fro the United States to the Territory that is subject to the Regulations, or in any other activity relating to the Territory subject to the Regulations; or C. Benefitting in any way from any transaction involving any item exported or to be exported from the United States to the Territory that is subject to the Regulations, or in any other activity relating to the Territory subject to the Regulations. Third, no person may, directly or indirectly, do any of the following: A. Export or reexport to or on behalf of the Denied Person any item subject to the Regulations from the United States to the Territory; E:\FR\FM\08FEN1.SGM 08FEN1

Agencies

[Federal Register Volume 73, Number 27 (Friday, February 8, 2008)]
[Notices]
[Page 7525]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-2373]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Bureau of Economic Analysis


Submission for OMB Review; Comment Request; Correction

AGENCY: Bureau of Economic Analysis (BEA), Department of Commerce.
    This notice corrects the notice published on February 1, 2008, 
Volume 73, Number 22, page 6114. The following items are corrected and 
replaced--
    Title: Biomedical Research and Development Price Index (BRDPI) 
Survey.
    OMB Control Number: 0608-0069.
    All other information stated in the February 1, 2008 notice remains 
effective.

    Dated: February 5, 2008.
Gwellnar Banks,
Management Analyst, Office of the Chief Information Officer.
[FR Doc. E8-2373 Filed 2-7-08; 8:45 am]
BILLING CODE 3510-06-P